22Sep 2024
Fetal Therapy Advances in Congenital Diaphragmatic Hernia Management

Fetal Therapy Advances in Congenital Diaphragmatic Hernia Management

Congenital diaphragmatic hernia (CDH) affects approximately 1 in 2,500 to 5,000 infants and is associated with significant neonatal morbidity and mortality, primarily due to pulmonary hypoplasia and pulmonary hypertension. Perinatal mortality rates range from 30% to 40%. Recent advances in neonatal care and surgical management, alongside improved prenatal diagnosis and intervention, suggest potential reductions in mortality. Data from the international TOTAL trials indicate the efficacy of fetal endoscopic tracheal occlusion (FETO) in severe left CDH. However, this intervention carries risks of significant morbidity, particularly related to prematurity and potential iatrogenic mortality if occlusion reversal fails. Cautious implementation of FETO in Level III fetal therapy centers, with rigorous monitoring and integration with expert neonatal CDH centers, is essential. Further research i

  • #pediatrics

Like

Save

Share